Channel Therapeutics Highlight NaV1.7 vs NaV1.8 in Suzetrigine
20 Dec 2024 //
GLOBENEWSWIRE
Vertex Dips on Mixed Ph 2 Data for Non-Opioid Pain Therapy
20 Dec 2024 //
BIOSPACE
Vertex Reports First Quarter 2024 Financial Results
06 May 2024 //
BUSINESSWIRE
Vertex announces advancements of pain signal inhibitor, suzetrigine
20 Apr 2024 //
PHARMABIZ
Vertex Updates On Suzetrigine For Acute And Neuropathic Pain
18 Apr 2024 //
BUSINESSWIRE